Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Brigham and Women’s Hospital nurses are speaking out in opposition to plans to merge the hospital’s burn unit with Mass General’s in 2026, which they argue damages generations of institutional ...

COLUMBUS, Ohio -- Ohio may start paying its small towns and villages to merge. A new bill at the statehouse would create a $25 million grant program to reward local governments that combine into one ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

This guest essay reflects the views of Marc Herbst, the executive director of the Long Island Contractors' Association. This month, Long Island achieved an important victory: ensuring that critical ...

Public safety officials are recommending the consolidation of Fayetteville and Cumberland County's 911 call centers. Recommendations for the joint center include no job losses, shared costs and using ...

Elon University and Queens University of Charlotte, private institutions roughly two hours apart, announced Tuesday that they plan to merge, with more details to come in the next few months. Although ...